These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 36796986)
21. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Liu X; Dai Q; Ye R; Zi W; Liu Y; Wang H; Zhu W; Ma M; Yin Q; Li M; Fan X; Sun W; Han Y; Lv Q; Liu R; Yang D; Shi Z; Zheng D; Deng X; Wan Y; Wang Z; Geng Y; Chen X; Zhou Z; Liao G; Jin P; Liu Y; Liu X; Zhang M; Zhou F; Shi H; Zhang Y; Guo F; Yin C; Niu G; Zhang M; Cai X; Zhu Q; Chen Z; Liang Y; Li B; Lin M; Wang W; Xu H; Fu X; Liu W; Tian X; Gong Z; Shi H; Wang C; Lv P; Tao Z; Zhu L; Yang S; Hu W; Jiang P; Liebeskind DS; Pereira VM; Leung T; Yan B; Davis S; Xu G; Nogueira RG; Lancet Neurol; 2020 Feb; 19(2):115-122. PubMed ID: 31831388 [TBL] [Abstract][Full Text] [Related]
22. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults. Palmer MJ; Barnard S; Perel P; Free C Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012675. PubMed ID: 29932455 [TBL] [Abstract][Full Text] [Related]
23. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial. Ramachandran A; Snehalatha C; Ram J; Selvam S; Simon M; Nanditha A; Shetty AS; Godsland IF; Chaturvedi N; Majeed A; Oliver N; Toumazou C; Alberti KG; Johnston DG Lancet Diabetes Endocrinol; 2013 Nov; 1(3):191-8. PubMed ID: 24622367 [TBL] [Abstract][Full Text] [Related]
24. Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials. Rothwell PM; Algra A; Chen Z; Diener HC; Norrving B; Mehta Z Lancet; 2016 Jul; 388(10042):365-375. PubMed ID: 27209146 [TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of GABA Chabriat H; Bassetti CL; Marx U; Audoli-Inthavong ML; Sors A; Lambert E; Wattez M; Hermann DM; Lancet Neurol; 2020 Mar; 19(3):226-233. PubMed ID: 32085836 [TBL] [Abstract][Full Text] [Related]
26. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
27. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial. Yang P; Song L; Zhang Y; Zhang X; Chen X; Li Y; Sun L; Wan Y; Billot L; Li Q; Ren X; Shen H; Zhang L; Li Z; Xing P; Zhang Y; Zhang P; Hua W; Shen F; Zhou Y; Tian B; Chen W; Han H; Zhang L; Xu C; Li T; Peng Y; Yue X; Chen S; Wen C; Wan S; Yin C; Wei M; Shu H; Nan G; Liu S; Liu W; Cai Y; Sui Y; Chen M; Zhou Y; Zuo Q; Dai D; Zhao R; Li Q; Huang Q; Xu Y; Deng B; Wu T; Lu J; Wang X; Parsons MW; Butcher K; Campbell B; Robinson TG; Goyal M; Dippel D; Roos Y; Majoie C; Wang L; Wang Y; Liu J; Anderson CS; Lancet; 2022 Nov; 400(10363):1585-1596. PubMed ID: 36341753 [TBL] [Abstract][Full Text] [Related]
28. Chronic remote ischaemic conditioning in patients with symptomatic intracranial atherosclerotic stenosis (the RICA trial): a multicentre, randomised, double-blind sham-controlled trial in China. Hou C; Lan J; Lin Y; Song H; Wang Y; Zhao W; Li S; Meng R; Hao J; Ding Y; Chimowitz MI; Fisher M; Hess DC; Liebeskind DS; Hausenloy DJ; Huang J; Li Z; Han X; Yang J; Zhou J; Chen P; Zhu X; Hu P; Pang H; Chen W; Chen H; Li G; Tao D; Yue W; Gao Z; Ji X; Lancet Neurol; 2022 Dec; 21(12):1089-1098. PubMed ID: 36354026 [TBL] [Abstract][Full Text] [Related]
29. The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial. Gerstein HC; Hart R; Colhoun HM; Diaz R; Lakshmanan M; Botros FT; Probstfield J; Riddle MC; Rydén L; Atisso CM; Dyal L; Hall S; Avezum A; Basile J; Conget I; Cushman WC; Hancu N; Hanefeld M; Jansky P; Keltai M; Lanas F; Leiter LA; Lopez-Jaramillo P; Muñoz EGC; Pogosova N; Raubenheimer PJ; Shaw JE; Sheu WH; Temelkova-Kurktschiev T Lancet Diabetes Endocrinol; 2020 Feb; 8(2):106-114. PubMed ID: 31924562 [TBL] [Abstract][Full Text] [Related]
30. Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial. Hankey GJ; Eikelboom JW; Yi Q; Lees KR; Chen C; Xavier D; Navarro JC; Ranawaka UK; Uddin W; Ricci S; Gommans J; Schmidt R; Lancet Neurol; 2012 Jun; 11(6):512-20. PubMed ID: 22554931 [TBL] [Abstract][Full Text] [Related]
31. Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study. Haeusler KG; Kirchhof P; Kunze C; Tütüncü S; Fiessler C; Malsch C; Olma MC; Jawad-Ul-Qamar M; Krämer M; Wachter R; Michalski D; Kraft A; Rizos T; Gröschel K; Thomalla G; Nabavi DG; Röther J; Laufs U; Veltkamp R; Heuschmann PU; Endres M; Lancet Neurol; 2021 Jun; 20(6):426-436. PubMed ID: 34022169 [TBL] [Abstract][Full Text] [Related]
32. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT. Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153 [TBL] [Abstract][Full Text] [Related]